Total Payments
$1,279
2024 Payments
$202.90
Companies
15
Transactions
81
Medicare Patients
3,206
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$1,279 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,279 | 81 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $678.69 | 50 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $126.41 | 5 | $0 (2024) |
| Organogenesis Inc. | $124.30 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $62.35 | 3 | $0 (2024) |
| Osiris Therapeutics Inc. | $50.88 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $48.74 | 3 | $0 (2024) |
| Allergan Inc. | $32.98 | 2 | $0 (2017) |
| CVRx, Inc. | $29.08 | 2 | $0 (2022) |
| Hollister Incorporated | $24.49 | 2 | $0 (2018) |
| HARTMANN USA, INC. | $22.27 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $202.90 | 9 | Novartis Pharmaceuticals Corporation ($126.41) |
| 2023 | $36.08 | 2 | AstraZeneca Pharmaceuticals LP ($19.65) |
| 2022 | $91.37 | 6 | CVRx, Inc. ($29.08) |
| 2021 | $15.34 | 1 | Amgen Inc. ($15.34) |
| 2019 | $478.57 | 32 | Smith+Nephew, Inc. ($378.41) |
| 2018 | $250.31 | 18 | Smith & Nephew, Inc. ($164.44) |
| 2017 | $204.73 | 13 | Smith & Nephew, Inc. ($135.84) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Biological | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.62 | General |
| 02/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardio-renal | ||||||
| 05/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Pain Management | ||||||
| 10/11/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/18/2022 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Heart Failure and Hypertension | ||||||
| 03/18/2022 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Heart Failure and Hypertension | ||||||
| 02/08/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: RESPIRATORY | ||||||
| 03/25/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Inflammation | ||||||
| 12/16/2019 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Pharma Product | ||||||
| 12/16/2019 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: Pharma Product | ||||||
| 12/04/2019 | Smith+Nephew, Inc. | GrafixPL (Biological) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: Other Advanced Wound Management | ||||||
| 11/19/2019 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Pharma Product | ||||||
| 11/08/2019 | Smith+Nephew, Inc. | Grafix CORE (Biological) | Food and Beverage | In-kind items and services | $38.21 | General |
| Category: Other Advanced Wound Management | ||||||
| 11/06/2019 | Smith+Nephew, Inc. | Grafix PL PRIME (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Other Advanced Wound Management | ||||||
| 11/05/2019 | Smith+Nephew, Inc. | Grafix PL PRIME (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Other Advanced Wound Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 493 | 6,188 | $658,957 | $457,136 |
| 2022 | 16 | 804 | 6,165 | $768,396 | $401,712 |
| 2021 | 18 | 1,126 | 5,851 | $693,386 | $390,322 |
| 2020 | 13 | 783 | 3,269 | $679,204 | $234,100 |
Total Patients
3,206
Total Services
21,473
Medicare Billing
$1.5M
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 73 | 2,980 | $364,655 | $231,536 | 63.5% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 56 | 1,291 | $187,298 | $146,672 | 78.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 37 | 763 | $29,971 | $22,755 | 75.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 213 | $27,463 | $19,615 | 71.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 42 | 311 | $14,925 | $11,245 | 75.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 36 | 225 | $10,763 | $8,110 | 75.4% |
| G0317 | Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualifi | Facility | 2023 | 43 | 252 | $7,711 | $6,045 | 78.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $5,705 | $4,886 | 85.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 64 | $3,992 | $2,905 | 72.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 30 | $3,023 | $2,001 | 66.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $3,449 | $1,365 | 39.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 102 | 2,881 | $451,366 | $200,470 | 44.4% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 66 | 537 | $75,698 | $54,948 | 72.6% |
| 99358 | Extended patient service without direct patient contact, first hour | Facility | 2022 | 79 | 372 | $89,260 | $32,110 | 36.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 56 | 812 | $32,747 | $25,070 | 76.6% |
| 99358 | Extended patient service without direct patient contact, first hour | Office | 2022 | 44 | 185 | $20,505 | $15,926 | 77.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 151 | $21,116 | $14,048 | 66.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 64 | 333 | $17,535 | $13,370 | 76.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 62 | 316 | $15,726 | $11,957 | 76.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 51 | 177 | $11,227 | $8,802 | 78.4% |
| 99359 | Extended patient service without direct patient contact, each additional 30 minutes | Office | 2022 | 33 | 128 | $6,956 | $5,487 | 78.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 49 | 143 | $6,840 | $5,362 | 78.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $6,208 | $4,186 | 67.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $4,107 | $3,857 | 93.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 17 | 20 | $3,444 | $2,596 | 75.4% |
About Dr. John Yee, MD
Dr. John Yee, MD is a Hospitalist healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225094071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Yee, MD has received a total of $1,279 in payments from pharmaceutical and medical device companies, with $202.90 received in 2024. These payments were reported across 81 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,279).
As a Medicare-enrolled provider, Yee has provided services to 3,206 Medicare beneficiaries, totaling 21,473 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Family Medicine
- Location Sarasota, FL
- Active Since 04/21/2006
- Last Updated 09/25/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1225094071
Products in Payments
- Santyl (Drug) $463.59
- ENTRESTO (Drug) $101.79
- Grafix PL PRIME (Biological) $96.48
- Apligraf (Device) $82.89
- TRELEGY ELLIPTA (Drug) $62.35
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $50.88
- PICO (Device) $46.31
- Apligraf (Biological) $41.41
- Grafix CORE (Biological) $38.21
- FARXIGA (Drug) $34.49
- Barostim Neo System (Device) $29.08
- Regranex (Drug) $22.58
- Proximel (Device) $22.27
- Kerendia (Drug) $19.57
- LINZESS (Drug) $18.92
- Veozah (Drug) $18.43
- Otezla (Drug) $15.34
- AIRSUPRA (Drug) $14.25
- VRAYLAR (Drug) $14.06
- HYDROFERA (Device) $13.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Sarasota
Faisal Ahmad, Md, MD
Hospitalist — Payments: $5,707
Hospitalist $5,707
Dr. Amit Shah, M.d, M.D
Hospitalist — Payments: $3,417
Hospitalist $3,417
Zachary Brewer, M.d, M.D
Hospitalist — Payments: $2,593
Hospitalist $2,593
Dr. Amy Roth, Do, DO
Hospitalist — Payments: $2,265
Hospitalist $2,265
Harsh Shah, Md, MD
Hospitalist — Payments: $1,437
Hospitalist $1,437
Mr. Kristofer Lambert, D.o, D.O
Hospitalist — Payments: $1,347
Hospitalist $1,347